Regentis Biomaterials Ltd. (RGNT) Net income 2023–2025
Regentis Biomaterials Ltd. (RGNT) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$13.6MFY2025 · since FY2023: -$4.1M → -$13.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$13.6M | -384.3% |
| FY2024 | $4.8M | +216.2% |
| FY2023 | -$4.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RGNT financial trends
RGNT RevenueRGNT Net marginRGNT Gross profitRGNT Gross marginRGNT Operating incomeRGNT Operating marginRGNT Operating cash flowRGNT Free cash flowRGNT Capital expendituresRGNT Return on equityRGNT Stock buybacksRGNT Dividends paidRGNT Total assetsRGNT Total liabilitiesRGNT Shareholders’ equityRGNT overview →